Julie Milton
Family · Saint Louis, MONPI 1912523788
Payments from drug & device makers
Across 59 payments — averaging $90.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$828
- Novo Nordisk$492
- AbbVie$469
- Amgen$449
- Axsome Therapeutics, Inc.$362
- Abbott$272
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,359100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $828 |
| Novo Nordisk | 10 | $492 |
| AbbVie | 4 | $469 |
| Amgen | 4 | $449 |
| Axsome Therapeutics, Inc. | 3 | $362 |
| Abbott | 2 | $272 |
| Neurelis, Inc. | 3 | $267 |
| Edwards Lifesciences | 3 | $244 |
| GSK | 2 | $232 |
| Bayer | 2 | $214 |
| Tris Pharma Inc | 2 | $193 |
| Teva Pharmaceuticals USA, Inc. | 2 | $180 |
| Collegium Pharmaceutical, Inc. | 2 | $178 |
| Mallinckrodt Hospital Products Inc. | 1 | $130 |
| Kyowa Kirin, Inc. | 1 | $122 |
| Sanofi | 1 | $117 |
| Genentech USA, Inc. | 1 | $106 |
| Exeltis, USA Inc. | 1 | $102 |
| Tactile Systems Technology Inc | 1 | $101 |
| Corcept Therapeutics | 1 | $89 |
| Neurocrine Biosciences, Inc. | 1 | $83 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Idorsia Pharmaceuticals US Inc | 1 | $46 |
| Lilly USA, LLC | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$469
- Auvelity$362
- FASENRA$334
- FREESTYLE LIBRE 3$272
- VALTOCO$234
- Kerendia$214
- Repatha$132
- TERLIVAZ$130
- JORNAY PM$125
- Ozempic$125
- Edwards SAPIEN 3 Transcatheter Heart Valve$123
- SHINGRIX$123
- AIRSUPRA$123
- CRYSVITA$122
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$120
- FABRAZYME$117
- UZEDY$110
- Dyanavel XR$110
- Quillivant$110
- Quillichew ER$110
How this compares
$5,360 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 48 | $7,728 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $470 |
| Mirtazapine | 28 | $409 |
| Atorvastatin Calcium | 42 | $169 |
| Famotidine | 28 | $146 |
| Fluticasone Propionate | 11 | $116 |
| Omeprazole | 12 | $74 |
| Prednisone | 11 | $10 |
| Losartan Potassium | 15 | $1 |
Paid to pharmacies, not to this prescriber.
Other family in Saint Louis
- Rebecca SeabaughSaint Louis$68K
- Jordan PerezSaint Louis$43K
- Lindsay GwaltneySaint Louis$28K
- Sara WoottenSaint Louis$21K
- Kelly RobertsSaint Louis$17K
- Matthew CarySaint Louis$15K
- Philip DudakSaint Louis$14K
- Kenan SahbazSaint Louis$14K
- Nicole CarrSaint Louis$14K
- Ashley GarrettSaint Louis$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.